GlassScriptPhysician profile
Erin M Sloan
NPI 1881352722
$2,711.68
in general payments reported to CMS, 2019-2025
27 companies · $630 in 2025
The $630 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $915 · 2023: $563 · 2024: $605 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,797.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $422.12 | 2022-2025 | |
| Aspira Women'S Health INC | $313.48 | 2022-2024 | Ova1 |
| Biogen, INC. | $304.46 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $241.70 | 2022-2025 | |
| Shield Therapeutics INC | $229.46 | 2023-2025 | Accrufer |
| Organon LLC | $138.69 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $112.15 | 2022-2025 | Slynd |
| Myovant Sciences INC. | $92.35 | 2022 | |
| Millicent US INC | $89.11 | 2022-2025 | Intrarosa, Femring |
| Novo Nordisk INC | $88.72 | 2022-2023 | Wegovy, Saxenda |
| Sumitomo Pharma America, INC. | $84.98 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $74.32 | 2022-2024 | Veozah |
| Pfizer INC. | $72.89 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $65.92 | 2022 | |
| Daiichi Sankyo INC. | $65.59 | 2022-2024 | Injectafer |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $44.50 | 2022-2024 | Prolia, Evenity |
| Boston Scientific Corporation | $36.04 | 2022-2023 | Advantage System |
| Baxter Healthcare | $35.74 | 2024 | Perclot |
| Channel Medsystems, INC. | $34.12 | 2023 | |
| Hologic Sales and Service, LLC | $30.78 | 2022-2025 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $25.51 | 2022-2025 | |
| Urovant Sciences INC | $22.98 | 2022 | |
| Coopersurgical, INC. | $22.87 | 2025 | Paragard T 380a |
| Sage Therapeutics, LLC | $20.48 | 2022 | |
| Exact Sciences Corporation | $16.94 | 2023 | Cologuard Collection Kit |
| Radius Health, INC. | $14.03 | 2025 | Tymlos |
| Therapeuticsmd, INC. | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Sloan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.